Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Capital in Excess of Par Value	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Oct. 30, 2021		525,331,000
Beginning balance at Oct. 30, 2021		$ 87,554	$ 30,574,237	$ 7,517,316	$ (186,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 280,077			280,077
Dividends declared and paid				(362,645)
Issuance of stock under stock plans and other (in shares)		579,000
Issuance of stock under stock plans and other		$ 100	8,371
Stock-based compensation expense			86,939
Other comprehensive income (loss)	$ (2,053)				(2,053)
Common stock repurchased (in shares)		(2,595,000)
Common stock repurchased		$ (433)	(575,586)
Ending balance (in shares) at Jan. 29, 2022		523,315,000
Ending balance at Jan. 29, 2022		$ 87,221	30,093,961	7,434,748	(188,618)
Beginning balance (in shares) at Oct. 29, 2022	509,295,941	509,296,000
Beginning balance at Oct. 29, 2022	$ 36,465,323	$ 84,880	27,857,270	8,721,325	(198,152)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	961,474			961,474
Dividends declared and paid				(385,452)
Issuance of stock under stock plans and other (in shares)		617,000
Issuance of stock under stock plans and other		$ 103	41,135
Stock-based compensation expense			75,041
Other comprehensive income (loss)	$ 28,418				28,418
Common stock repurchased (in shares)		(4,061,000)
Common stock repurchased		$ (677)	(653,880)
Ending balance (in shares) at Jan. 28, 2023	505,852,499	505,852,000
Ending balance at Jan. 28, 2023	$ 36,531,485	$ 84,306	$ 27,319,566	$ 9,297,347	$ (169,734)